That high design of purest gold: a critical history of the pharmaceutical industry 1880-2020
What is the Pharmaceutical Industry? -- Regulating Corporate Medicine -- Cells, Germs, Receptors and Magic Bullets : From Ancient to Modern Theories of the Body, Disease, and Drug Action -- From the Dyeing Arts to Drugs : Dye-making, Pharmacy and the new Research Corporation -- Making Hormones -- Th...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Singapore
World Scientific
[2020]
|
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Zusammenfassung: | What is the Pharmaceutical Industry? -- Regulating Corporate Medicine -- Cells, Germs, Receptors and Magic Bullets : From Ancient to Modern Theories of the Body, Disease, and Drug Action -- From the Dyeing Arts to Drugs : Dye-making, Pharmacy and the new Research Corporation -- Making Hormones -- The Anti-infectives : Sulphonamide, Penicillin and the Antibiotics -- Biotechnology, Personalisation, Precision, and the Digital Turn -- Intellectual Property in Biomedicine -- Prescriptions for a Healthier Pharmaceutical Industry "This book is a history of medicines and the commercial actors that make and sell them, covering the 140 years since the modern pharmaceutical industry came into being. It is written in a lively and accessible way, aiming at a general audience that combines historical narrative with fascinating case studies on drug discovery and commercialization, from the rat poison that became warfarin, to a cardiovascular treatment that was turned into Viagra. In a non-partisan way it also examines some of the less noble manifestations of corporate behavior, concluding with an agenda for reform. It is hard to think of anything nobler than to bring to the world a medicine that saves lives. And over 140 years of history, the pharmaceutical industry has produced a range of remarkable products, albeit typically with external scientific and financial support. Making medicines is a very big and profit-driven business, and the industry does not always make the right products for the right people, or at the right prices. The industry wields immense power over lives and economies. How has it risen to this position of dominance? Are the interests of the industry and the public in balance? What should we admire about the industry? What should we criticise and seek to change? The importance of this book lies in the fact that we are all stakeholders in this industry whether or not we own shares, so we all need answers to these questions." |
| Beschreibung: | Includes bibliographical references and index |
| Beschreibung: | xiv, 510 Seiten Illustrationen 24 cm |
| ISBN: | 9789811222474 9789811249921 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV047270476 | ||
| 003 | DE-604 | ||
| 005 | 20220428 | ||
| 007 | t | ||
| 008 | 210505s2020 xxua||| |||| 00||| eng d | ||
| 020 | |a 9789811222474 |c hardcover |9 978-981-122-247-4 | ||
| 020 | |a 9789811249921 |c softcover |9 978-981-124-992-1 | ||
| 035 | |a (OCoLC)1191836246 | ||
| 035 | |a (DE-599)KXP1699744009 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 044 | |a xxu |c XD-US | ||
| 049 | |a DE-210 |a DE-578 |a DE-19 |a DE-355 | ||
| 050 | 0 | |a RA401.A3 | |
| 082 | 0 | |a 338.4/76151 | |
| 084 | |a HIST |q DE-210 |2 fid | ||
| 084 | |a VB 2400 |0 (DE-625)147007:253 |2 rvk | ||
| 084 | |a XB 5000 |0 (DE-625)152475:12905 |2 rvk | ||
| 100 | 1 | |a Dutfield, Graham |d 1960- |e Verfasser |0 (DE-588)1253409900 |4 aut | |
| 245 | 1 | 0 | |a That high design of purest gold |b a critical history of the pharmaceutical industry 1880-2020 |c Graham Dutfield (University of Leeds, UK) |
| 264 | 1 | |a Singapore |b World Scientific |c [2020] | |
| 300 | |a xiv, 510 Seiten |b Illustrationen |c 24 cm | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 500 | |a Includes bibliographical references and index | ||
| 520 | 3 | |a What is the Pharmaceutical Industry? -- Regulating Corporate Medicine -- Cells, Germs, Receptors and Magic Bullets : From Ancient to Modern Theories of the Body, Disease, and Drug Action -- From the Dyeing Arts to Drugs : Dye-making, Pharmacy and the new Research Corporation -- Making Hormones -- The Anti-infectives : Sulphonamide, Penicillin and the Antibiotics -- Biotechnology, Personalisation, Precision, and the Digital Turn -- Intellectual Property in Biomedicine -- Prescriptions for a Healthier Pharmaceutical Industry | |
| 520 | 3 | |a "This book is a history of medicines and the commercial actors that make and sell them, covering the 140 years since the modern pharmaceutical industry came into being. It is written in a lively and accessible way, aiming at a general audience that combines historical narrative with fascinating case studies on drug discovery and commercialization, from the rat poison that became warfarin, to a cardiovascular treatment that was turned into Viagra. In a non-partisan way it also examines some of the less noble manifestations of corporate behavior, concluding with an agenda for reform. It is hard to think of anything nobler than to bring to the world a medicine that saves lives. And over 140 years of history, the pharmaceutical industry has produced a range of remarkable products, albeit typically with external scientific and financial support. Making medicines is a very big and profit-driven business, and the industry does not always make the right products for the right people, or at the right prices. The industry wields immense power over lives and economies. How has it risen to this position of dominance? Are the interests of the industry and the public in balance? What should we admire about the industry? What should we criticise and seek to change? The importance of this book lies in the fact that we are all stakeholders in this industry whether or not we own shares, so we all need answers to these questions." | |
| 648 | 7 | |a Geschichte 1880-2020 |2 gnd |9 rswk-swf | |
| 650 | 0 | 7 | |a Arzneimittel |0 (DE-588)4003115-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmakologie |0 (DE-588)4045687-0 |2 gnd |9 rswk-swf |
| 653 | 4 | |a 1880-2020 | |
| 653 | 0 | |a Pharmaindustrie / (DE-627)091383137 / (DE-STW)13002-3 | |
| 653 | 0 | |a Arzneimittel / (DE-627)091383145 / (DE-STW)14728-1 | |
| 653 | 0 | |a Pharmakologie / (DE-627)091383129 / (DE-STW)19785-6 | |
| 653 | 0 | |a Wirtschaftsgeschichte / (DE-627)091400961 / (DE-STW)15706-6 | |
| 653 | 0 | |a Drug Industry / History | |
| 653 | 0 | |a Pharmaceutical research / History | |
| 653 | 0 | |a Economics, Pharmaceutical / History | |
| 689 | 0 | 0 | |a Pharmakologie |0 (DE-588)4045687-0 |D s |
| 689 | 0 | 1 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |D s |
| 689 | 0 | 2 | |a Arzneimittel |0 (DE-588)4003115-9 |D s |
| 689 | 0 | 3 | |a Geschichte 1880-2020 |A z |
| 689 | 0 | |5 DE-604 | |
| 776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |z 978-981-122-249-8 |
| 776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |z 978-981-122-248-1 |
| 856 | 4 | 2 | |m Digitalisierung Deutsches Museum |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=032674171&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-032674171 | ||
Datensatz im Suchindex
| _version_ | 1804182427195670528 |
|---|---|
| adam_text | CONTENTS
PREFACE
XI
CHAPTER
1
INTRODUCTION
1
PART
1
THE NATURE
OF
THE
PHARMACEUTICAL
INDUSTRY
23
CHAPTER
2
WHAT
IS
THE
PHARMACEUTICAL
INDUSTRY?
25
CHAPTER
3
REGULATING
CORPORATE
MEDICINE
71
PART
2
ANTECEDENTS,
ORIGINS,
AND
THE
EMERGENCE
OF
A
NEW INDUSTRY
127
CHAPTER
4
CELLS,
GERMS, RECEPTORS,
AND
MAGIC
BULLETS:
FROM
ANCIENT
TO
MODERN
THEORIES
OF
THE
BODY,
DISEASE,
DRUGS,
AND
DRUG
ACTION
129
CHAPTER
5 FROM
THE
DYEING
ARTS
TO
DRUGS:
OR
DYE-MAKING,
PHARMACY,
AND
THE
NEW
RESEARCH
CORPORATION
162
PART
3
SCIENCE,
BUSINESS
STRATEGY,
AND
GROWTH
217
CHAPTER
6
MAKING
HORMONES
219
CHAPTER
7 THE ANTI-INFECTIVES:
SULPHONAMIDE,
PENICILLIN,
AND
THE
ANTIBIOTICS
245
CHAPTER
8 BIOTECHNOLOGY,
PERSONALISATION,
PRECISION,
AND
THE
DIGITAL
TURN
275
CHAPTER
9 INTELLECTUAL
PROPERTY
IN
BIOMEDICINE
345
XIII
$
B1IOTHEK
DEUTSCHES
MUSEUM
HLUENCHE A
XIV
THAT
HIGH
DESIGN
OF
PUREST
GOLD
PART 4
THE PHARMACEUTICAL
SECTOR
AND
THE
PUBLIC
INTEREST
421
CHAPTER 10
PRESCRIPTIONS
FOR
A
HEALTHIER
PHARMACEUTICAL
INDUSTRY
423
BIBLIOGRAPHY
453
INDEX
495
|
| adam_txt |
CONTENTS
PREFACE
XI
CHAPTER
1
INTRODUCTION
1
PART
1
THE NATURE
OF
THE
PHARMACEUTICAL
INDUSTRY
23
CHAPTER
2
WHAT
IS
THE
PHARMACEUTICAL
INDUSTRY?
25
CHAPTER
3
REGULATING
CORPORATE
MEDICINE
71
PART
2
ANTECEDENTS,
ORIGINS,
AND
THE
EMERGENCE
OF
A
NEW INDUSTRY
127
CHAPTER
4
CELLS,
GERMS, RECEPTORS,
AND
MAGIC
BULLETS:
FROM
ANCIENT
TO
MODERN
THEORIES
OF
THE
BODY,
DISEASE,
DRUGS,
AND
DRUG
ACTION
129
CHAPTER
5 FROM
THE
DYEING
ARTS
TO
DRUGS:
OR
DYE-MAKING,
PHARMACY,
AND
THE
NEW
RESEARCH
CORPORATION
162
PART
3
SCIENCE,
BUSINESS
STRATEGY,
AND
GROWTH
217
CHAPTER
6
MAKING
HORMONES
219
CHAPTER
7 THE ANTI-INFECTIVES:
SULPHONAMIDE,
PENICILLIN,
AND
THE
ANTIBIOTICS
245
CHAPTER
8 BIOTECHNOLOGY,
PERSONALISATION,
PRECISION,
AND
THE
DIGITAL
TURN
275
CHAPTER
9 INTELLECTUAL
PROPERTY
IN
BIOMEDICINE
345
XIII
$
B1IOTHEK
DEUTSCHES
MUSEUM
HLUENCHE'A
XIV
THAT
HIGH
DESIGN
OF
PUREST
GOLD
PART 4
THE PHARMACEUTICAL
SECTOR
AND
THE
PUBLIC
INTEREST
421
CHAPTER 10
PRESCRIPTIONS
FOR
A
HEALTHIER
PHARMACEUTICAL
INDUSTRY
423
BIBLIOGRAPHY
453
INDEX
495 |
| any_adam_object | 1 |
| any_adam_object_boolean | 1 |
| author | Dutfield, Graham 1960- |
| author_GND | (DE-588)1253409900 |
| author_facet | Dutfield, Graham 1960- |
| author_role | aut |
| author_sort | Dutfield, Graham 1960- |
| author_variant | g d gd |
| building | Verbundindex |
| bvnumber | BV047270476 |
| callnumber-first | R - Medicine |
| callnumber-label | RA401 |
| callnumber-raw | RA401.A3 |
| callnumber-search | RA401.A3 |
| callnumber-sort | RA 3401 A3 |
| callnumber-subject | RA - Public Medicine |
| classification_rvk | VB 2400 XB 5000 |
| ctrlnum | (OCoLC)1191836246 (DE-599)KXP1699744009 |
| dewey-full | 338.4/76151 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 338 - Production |
| dewey-raw | 338.4/76151 |
| dewey-search | 338.4/76151 |
| dewey-sort | 3338.4 576151 |
| dewey-tens | 330 - Economics |
| discipline | Chemie / Pharmazie Wirtschaftswissenschaften Medizin |
| discipline_str_mv | Chemie / Pharmazie Wirtschaftswissenschaften Medizin |
| era | Geschichte 1880-2020 gnd |
| era_facet | Geschichte 1880-2020 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04541nam a2200613 c 4500</leader><controlfield tag="001">BV047270476</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20220428 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">210505s2020 xxua||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9789811222474</subfield><subfield code="c">hardcover</subfield><subfield code="9">978-981-122-247-4</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9789811249921</subfield><subfield code="c">softcover</subfield><subfield code="9">978-981-124-992-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1191836246</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)KXP1699744009</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">XD-US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-210</subfield><subfield code="a">DE-578</subfield><subfield code="a">DE-19</subfield><subfield code="a">DE-355</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RA401.A3</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">338.4/76151</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">HIST</subfield><subfield code="q">DE-210</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VB 2400</subfield><subfield code="0">(DE-625)147007:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XB 5000</subfield><subfield code="0">(DE-625)152475:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Dutfield, Graham</subfield><subfield code="d">1960-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1253409900</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">That high design of purest gold</subfield><subfield code="b">a critical history of the pharmaceutical industry 1880-2020</subfield><subfield code="c">Graham Dutfield (University of Leeds, UK)</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Singapore</subfield><subfield code="b">World Scientific</subfield><subfield code="c">[2020]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xiv, 510 Seiten</subfield><subfield code="b">Illustrationen</subfield><subfield code="c">24 cm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="520" ind1="3" ind2=" "><subfield code="a">What is the Pharmaceutical Industry? -- Regulating Corporate Medicine -- Cells, Germs, Receptors and Magic Bullets : From Ancient to Modern Theories of the Body, Disease, and Drug Action -- From the Dyeing Arts to Drugs : Dye-making, Pharmacy and the new Research Corporation -- Making Hormones -- The Anti-infectives : Sulphonamide, Penicillin and the Antibiotics -- Biotechnology, Personalisation, Precision, and the Digital Turn -- Intellectual Property in Biomedicine -- Prescriptions for a Healthier Pharmaceutical Industry</subfield></datafield><datafield tag="520" ind1="3" ind2=" "><subfield code="a">"This book is a history of medicines and the commercial actors that make and sell them, covering the 140 years since the modern pharmaceutical industry came into being. It is written in a lively and accessible way, aiming at a general audience that combines historical narrative with fascinating case studies on drug discovery and commercialization, from the rat poison that became warfarin, to a cardiovascular treatment that was turned into Viagra. In a non-partisan way it also examines some of the less noble manifestations of corporate behavior, concluding with an agenda for reform. It is hard to think of anything nobler than to bring to the world a medicine that saves lives. And over 140 years of history, the pharmaceutical industry has produced a range of remarkable products, albeit typically with external scientific and financial support. Making medicines is a very big and profit-driven business, and the industry does not always make the right products for the right people, or at the right prices. The industry wields immense power over lives and economies. How has it risen to this position of dominance? Are the interests of the industry and the public in balance? What should we admire about the industry? What should we criticise and seek to change? The importance of this book lies in the fact that we are all stakeholders in this industry whether or not we own shares, so we all need answers to these questions."</subfield></datafield><datafield tag="648" ind1=" " ind2="7"><subfield code="a">Geschichte 1880-2020</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="653" ind1=" " ind2="4"><subfield code="a">1880-2020</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Pharmaindustrie / (DE-627)091383137 / (DE-STW)13002-3</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Arzneimittel / (DE-627)091383145 / (DE-STW)14728-1</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Pharmakologie / (DE-627)091383129 / (DE-STW)19785-6</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Wirtschaftsgeschichte / (DE-627)091400961 / (DE-STW)15706-6</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Drug Industry / History</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Pharmaceutical research / History</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Economics, Pharmaceutical / History</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Geschichte 1880-2020</subfield><subfield code="A">z</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield><subfield code="z">978-981-122-249-8</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield><subfield code="z">978-981-122-248-1</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">Digitalisierung Deutsches Museum</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=032674171&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-032674171</subfield></datafield></record></collection> |
| id | DE-604.BV047270476 |
| illustrated | Illustrated |
| index_date | 2024-07-03T17:13:54Z |
| indexdate | 2024-07-10T09:07:22Z |
| institution | BVB |
| isbn | 9789811222474 9789811249921 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-032674171 |
| oclc_num | 1191836246 |
| open_access_boolean | |
| owner | DE-210 DE-578 DE-19 DE-BY-UBM DE-355 DE-BY-UBR |
| owner_facet | DE-210 DE-578 DE-19 DE-BY-UBM DE-355 DE-BY-UBR |
| physical | xiv, 510 Seiten Illustrationen 24 cm |
| publishDate | 2020 |
| publishDateSearch | 2020 |
| publishDateSort | 2020 |
| publisher | World Scientific |
| record_format | marc |
| spelling | Dutfield, Graham 1960- Verfasser (DE-588)1253409900 aut That high design of purest gold a critical history of the pharmaceutical industry 1880-2020 Graham Dutfield (University of Leeds, UK) Singapore World Scientific [2020] xiv, 510 Seiten Illustrationen 24 cm txt rdacontent n rdamedia nc rdacarrier Includes bibliographical references and index What is the Pharmaceutical Industry? -- Regulating Corporate Medicine -- Cells, Germs, Receptors and Magic Bullets : From Ancient to Modern Theories of the Body, Disease, and Drug Action -- From the Dyeing Arts to Drugs : Dye-making, Pharmacy and the new Research Corporation -- Making Hormones -- The Anti-infectives : Sulphonamide, Penicillin and the Antibiotics -- Biotechnology, Personalisation, Precision, and the Digital Turn -- Intellectual Property in Biomedicine -- Prescriptions for a Healthier Pharmaceutical Industry "This book is a history of medicines and the commercial actors that make and sell them, covering the 140 years since the modern pharmaceutical industry came into being. It is written in a lively and accessible way, aiming at a general audience that combines historical narrative with fascinating case studies on drug discovery and commercialization, from the rat poison that became warfarin, to a cardiovascular treatment that was turned into Viagra. In a non-partisan way it also examines some of the less noble manifestations of corporate behavior, concluding with an agenda for reform. It is hard to think of anything nobler than to bring to the world a medicine that saves lives. And over 140 years of history, the pharmaceutical industry has produced a range of remarkable products, albeit typically with external scientific and financial support. Making medicines is a very big and profit-driven business, and the industry does not always make the right products for the right people, or at the right prices. The industry wields immense power over lives and economies. How has it risen to this position of dominance? Are the interests of the industry and the public in balance? What should we admire about the industry? What should we criticise and seek to change? The importance of this book lies in the fact that we are all stakeholders in this industry whether or not we own shares, so we all need answers to these questions." Geschichte 1880-2020 gnd rswk-swf Arzneimittel (DE-588)4003115-9 gnd rswk-swf Pharmazeutische Industrie (DE-588)4045696-1 gnd rswk-swf Pharmakologie (DE-588)4045687-0 gnd rswk-swf 1880-2020 Pharmaindustrie / (DE-627)091383137 / (DE-STW)13002-3 Arzneimittel / (DE-627)091383145 / (DE-STW)14728-1 Pharmakologie / (DE-627)091383129 / (DE-STW)19785-6 Wirtschaftsgeschichte / (DE-627)091400961 / (DE-STW)15706-6 Drug Industry / History Pharmaceutical research / History Economics, Pharmaceutical / History Pharmakologie (DE-588)4045687-0 s Pharmazeutische Industrie (DE-588)4045696-1 s Arzneimittel (DE-588)4003115-9 s Geschichte 1880-2020 z DE-604 Erscheint auch als Online-Ausgabe 978-981-122-249-8 Erscheint auch als Online-Ausgabe 978-981-122-248-1 Digitalisierung Deutsches Museum application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=032674171&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Dutfield, Graham 1960- That high design of purest gold a critical history of the pharmaceutical industry 1880-2020 Arzneimittel (DE-588)4003115-9 gnd Pharmazeutische Industrie (DE-588)4045696-1 gnd Pharmakologie (DE-588)4045687-0 gnd |
| subject_GND | (DE-588)4003115-9 (DE-588)4045696-1 (DE-588)4045687-0 |
| title | That high design of purest gold a critical history of the pharmaceutical industry 1880-2020 |
| title_auth | That high design of purest gold a critical history of the pharmaceutical industry 1880-2020 |
| title_exact_search | That high design of purest gold a critical history of the pharmaceutical industry 1880-2020 |
| title_exact_search_txtP | That high design of purest gold a critical history of the pharmaceutical industry 1880-2020 |
| title_full | That high design of purest gold a critical history of the pharmaceutical industry 1880-2020 Graham Dutfield (University of Leeds, UK) |
| title_fullStr | That high design of purest gold a critical history of the pharmaceutical industry 1880-2020 Graham Dutfield (University of Leeds, UK) |
| title_full_unstemmed | That high design of purest gold a critical history of the pharmaceutical industry 1880-2020 Graham Dutfield (University of Leeds, UK) |
| title_short | That high design of purest gold |
| title_sort | that high design of purest gold a critical history of the pharmaceutical industry 1880 2020 |
| title_sub | a critical history of the pharmaceutical industry 1880-2020 |
| topic | Arzneimittel (DE-588)4003115-9 gnd Pharmazeutische Industrie (DE-588)4045696-1 gnd Pharmakologie (DE-588)4045687-0 gnd |
| topic_facet | Arzneimittel Pharmazeutische Industrie Pharmakologie |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=032674171&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT dutfieldgraham thathighdesignofpurestgoldacriticalhistoryofthepharmaceuticalindustry18802020 |